Postoperative Intravenous Acetaminophen for Craniotomy Patients: A Randomized Controlled Trial

Area of Science:

• Neurosurgery
• Anesthesiology
• Pharmacology

Background:

• Postoperative pain management after craniotomy is crucial for patient recovery.
• Opioid use is common, but alternatives are being explored to minimize side effects.
• Intravenous acetaminophen offers a non-opioid option for pain control.

Purpose of the Study:

• To evaluate the effect of intravenous acetaminophen on opioid requirements in the initial 24 hours post-craniotomy.
• To compare postoperative pain management strategies using acetaminophen versus placebo.

Main Methods:

• A randomized controlled trial involving 140 patients undergoing craniotomy.
• Patients received either intravenous acetaminophen (1g every 6 hours) or placebo (normal saline).
• Opioid consumption and various clinical outcomes were assessed within the first 24 postoperative hours.

Main Results:

• A higher percentage of patients in the acetaminophen group did not require opioids (15.2% vs. 6.2%), but this difference was not statistically significant.
• No significant differences were observed in time to rescue medication, opioid amounts, length of stay, neurological assessments, sedation, delirium, or pain scores.
• Both groups reported similar patient satisfaction and temperature readings.

Conclusions:

• Intravenous acetaminophen did not significantly reduce opioid requirements in the first 24 hours after craniotomy compared to placebo.
• Findings suggest similar efficacy for both treatments regarding opioid use and other clinical outcomes.
• The study provides valuable data for designing future research on postoperative pain management in neurosurgical patients.